Birchview Capital »

Verastem shares owned by Birchview Capital

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Birchview Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 150k 7.72

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Compass Therapeutics (CMPX)
Stoke Therapeutics (STOK)
Lam Research Corporation Com New (LRCX)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Spons Adr (GPCR)
Protagonist Therapeutics (PTGX)
ACADIA Pharmaceuticals (ACAD)
Encana Corporation (OVV)
Prothena Corp SHS (PRTA)
Solid Biosciences Com New (SLDB)
Neurocrine Biosciences (NBIX)
Amicus Therapeutics (FOLD)
Bicycle Therapeutics Sponsored Ads (BCYC)

View all positions for Birchview Capital

Top funds holding Verastem

Rtw Investments
Deep Track Capital
BlackRock
Vanguard Group
Balyasny Asset Management
Polar Capital Holdings
State Street Corporation
Stonepine Capital Management
Foresite Capital Management VI
Armistice Capital
Farallon Capital Management
Rosalind Advisors
Logos Global Management
Goldman Sachs Group
Geode Capital Management

View all funds holding Verastem